← All decks

Dermatology

Pemphigus

Built from Dermatology, 5th Edition

What’s inside

11 sections · 118 slides

  1. 01

    Overview

    • What is pemphigus
    • How this topic is organised
    • Key features of pemphigus

    3 slides

  2. 02

    Classification, History, and Epidemiology

    The forms of pemphigus, how the disease was discovered, and who it affects

    • The three major forms of pemphigus
    • Classification of pemphigus
    • Classification of pemphigus
    • How pemphigus was discovered
    • Indirect immunofluorescence in pemphigus
    • Who gets pemphigus
    • Regional patterns in pemphigus subtype

    7 slides

  3. 03

    Fogo Selvagem

    An endemic form of pemphigus foliaceus in rural Brazil, and a natural experiment in how autoimmunity can be triggered

    • What is fogo selvagem
    • The insect-bite theory of fogo selvagem
    • A natural experiment in autoimmunity
    • From harmless antibody to disease-causing antibody

    4 slides

  4. 04

    Pathogenesis: Autoantibodies and Desmogleins

    How IgG antibodies against desmogleins actually pull skin cells apart

    • Pemphigus IgG causes blisters by itself
    • Desmogleins: the glue that pemphigus attacks
    • Cadherins: calcium-dependent cell glue
    • Two kinds of cell-cell junction in the skin
    • The desmoglein family and its partners
    • Proof that anti-desmoglein antibodies cause disease
    • The desmoglein compensation theory
    • Which antibody profile causes which disease
    • Why anti-Dsg1 alone spares the mucosa
    • Why anti-Dsg3 alone favours the mouth
    • Desmoglein compensation theory illustrated
    • Two more clues that support compensation theory
    • How the antibody actually breaks the glue

    13 slides

  5. 05

    Autoimmunity in Paraneoplastic Pemphigus

    A double attack - antibodies plus T cells - and the reference table of every known pemphigus target antigen

    • Two autoimmune attacks in paraneoplastic pemphigus
    • What T cells do in paraneoplastic pemphigus
    • Why patients start making these antibodies
    • Target antigens across the pemphigus family
    • Target antigens in pemphigus
    • Target antigens in pemphigus (continued)
    • Target antigens in pemphigus (continued)

    7 slides

  6. 06

    Clinical Features: Pemphigus Vulgaris

    Painful mouth erosions, fragile skin blisters, and the bedside signs that reveal fragile skin

    • Two subgroups of pemphigus vulgaris
    • Oral involvement in pemphigus vulgaris
    • Skin lesions of pemphigus vulgaris
    • What pemphigus vulgaris looks like on the skin
    • Unusual clinical presentations of pemphigus vulgaris
    • Unusual clinical presentations of pemphigus vulgaris
    • Bedside signs of fragile skin
    • Pemphigus vegetans
    • Pemphigus vegetans
    • Pemphigus vulgaris: flaccid blister and erosion

    10 slides

  7. 07

    Pemphigus Foliaceus and Its Variants

    A superficial, skin-only pattern of pemphigus, and the localized, endemic, herpetiform, and drug-induced variants built on it

    • What pemphigus foliaceus looks like
    • Pemphigus foliaceus: superficial erosions
    • Pemphigus foliaceus: erosions and thick scale-crusts
    • Pemphigus foliaceus of the scalp
    • Generalized pemphigus foliaceus
    • Pemphigus erythematosus (Senear-Usher syndrome)
    • Pemphigus erythematosus
    • Herpetiform pemphigus
    • Drug-induced pemphigus

    9 slides

  8. 08

    Paraneoplastic Pemphigus and IgA Pemphigus

    A tumour-associated, multi-organ disease, and a milder, pustular, IgA-driven form of pemphigus

    • The tumours behind paraneoplastic pemphigus
    • The hallmark of paraneoplastic pemphigus
    • Skin findings and complications of paraneoplastic pemphigus
    • Paraneoplastic pemphigus: fragile blisters
    • What is IgA pemphigus
    • What IgA pemphigus looks like
    • IgA pemphigus: sunflower-like pustule pattern
    • IgA pemphigus: targets and associations

    8 slides

  9. 09

    Pathology

    What a biopsy shows in each form of pemphigus, and how to take one correctly

    • How to biopsy a suspected pemphigus lesion
    • Preferred biopsy sites in autoimmune bullous disease
    • Pemphigus vulgaris: histology
    • Suprabasilar acantholysis in pemphigus vulgaris
    • Causes of eosinophilic spongiosis
    • Causes of eosinophilic spongiosis
    • Pemphigus foliaceus: histology
    • Pemphigus foliaceus: histopathologic features
    • Pemphigus foliaceus: cleavage within the granular layer
    • Pemphigus foliaceus: clefting in the upper spinous layer
    • Paraneoplastic pemphigus: histology
    • Paraneoplastic pemphigus: histopathologic features
    • IgA pemphigus: histology
    • IgA pemphigus: histopathologic features

    14 slides

  10. 10

    Diagnosis and Differential Diagnosis

    How pemphigus antibodies are actually detected, and the look-alike diseases each subtype must be told apart from

    • The gold standard: finding the autoantibody itself
    • Direct and indirect immunofluorescence techniques
    • What DIF and IIF actually show
    • Choosing the right IIF substrate
    • IIF for pemphigus and bullous pemphigoid - recommended substrates
    • Identifying the exact antigen: ELISA and beyond
    • How ELISA distinguishes the subtypes
    • ELISA target autoantigens across autoimmune bullous diseases
    • Differential diagnosis of pemphigus vulgaris
    • Differential diagnosis of pemphigus vegetans
    • Pemphigus vegetans - differential diagnosis
    • Differential diagnosis of pemphigus foliaceus
    • Differential diagnosis of paraneoplastic pemphigus
    • Disorders that crust the lips like paraneoplastic pemphigus
    • Disorders with hemorrhagic crusts of the vermilion lips
    • Hemorrhagic crusting of the vermilion lips
    • Differential diagnosis of IgA pemphigus

    17 slides

  11. 11

    Treatment

    From a once-fatal disease to a manageable one - corticosteroids, steroid-sparing agents, and modern B cell-targeted therapy

    • Why treatment must target antibody production
    • Systemic corticosteroids: the mainstay
    • Immunosuppressive steroid-sparing agents
    • Tapering and long-term strategy
    • Plasmapheresis and high-dose IVIg
    • Rituximab: B cell-depleting therapy
    • Emerging targeted therapies
    • The therapeutic ladder for pemphigus vulgaris
    • Therapeutic ladder for pemphigus vulgaris
    • Therapeutic ladder for pemphigus vulgaris (continued)
    • Treatment of pemphigus foliaceus
    • Treatment of paraneoplastic pemphigus
    • Treatment of IgA pemphigus
    • Summary: telling the pemphigus family apart
    • Key take-home points
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    26 slides